These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15638899

  • 1. Systemic stress responses in patients undergoing surgery for benign prostatic hyperplasia.
    Ruzic B, Tomaskovic I, Trnski D, Kraus O, Bekavac-Beslin M, Vrkic N.
    BJU Int; 2005 Jan; 95(1):77-80. PubMed ID: 15638899
    [Abstract] [Full Text] [Related]

  • 2. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A.
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [Abstract] [Full Text] [Related]

  • 3. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia.
    Aydin A, Arsova-Sarafinovska Z, Sayal A, Eken A, Erdem O, Erten K, Ozgök Y, Dimovski A.
    Clin Biochem; 2006 Feb; 39(2):176-9. PubMed ID: 16413012
    [Abstract] [Full Text] [Related]

  • 4. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
    Tanaka Y, Masumori N, Itoh N, Furuya S, Ogura H, Tsukamoto T.
    Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
    [Abstract] [Full Text] [Related]

  • 5. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
    Alemu MH.
    Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of transurethral surgical methods for treating small-size prostate hyperplasia].
    Dong ZQ, Li KJ, Zhang P, Zhang LS, Mao Z.
    Zhonghua Nan Ke Xue; 2007 Feb; 13(2):150-2. PubMed ID: 17345773
    [Abstract] [Full Text] [Related]

  • 7. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
    van Renterghem K, Van Koeveringe G, Achten R, Van Kerrebroeck P.
    Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
    [Abstract] [Full Text] [Related]

  • 8. [Therapeutic efficacy of bipolar plasmakinetic technique compared with transurethral resection on benign prostate hyperplasia].
    Wu WJ, Wang XH, Wang HP, Zou WB, Liang XY, Cai ZG, Zhong WW, Zou YF, Yuan DZ.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3365-7. PubMed ID: 16409848
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer.
    Arsova-Sarafinovska Z, Eken A, Matevska N, Erdem O, Sayal A, Savaser A, Banev S, Petrovski D, Dzikova S, Georgiev V, Sikole A, Ozgök Y, Suturkova L, Dimovski AJ, Aydin A.
    Clin Biochem; 2009 Aug 14; 42(12):1228-35. PubMed ID: 19465015
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinic analysis of repeat prostatectomy after transurethral prostatectomy for benign prostatic hyperplasia].
    Mao QZ, Rong S, Li HZ, Ji ZG, Xia M, Zang MF.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):372-4. PubMed ID: 15061986
    [Abstract] [Full Text] [Related]

  • 13. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT, Anderson CB, Fought A, Kim DY, Vyas A, McVary KT.
    Urology; 2009 Jul 02; 74(1):177-83. PubMed ID: 19428074
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z, Liu J, Li S, Shen W.
    Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463
    [Abstract] [Full Text] [Related]

  • 16. [Implementation of a clinical pathway for transurethral resection in benign prostatic hyperplasia].
    Sánchez Merino JM, Parra Muntaner L, Gómez Cisneros SC, Monsalve Rodríguez M, Jiménez Rodríguez M, García Alonso J.
    Arch Esp Urol; 2002 Mar 01; 55(2):131-44. PubMed ID: 12014045
    [Abstract] [Full Text] [Related]

  • 17. Preoperative administration of chlormadinone acetate reduces blood loss associated with transurethral resection of the prostate: a prospective randomized study.
    Ukimura O, Kawauchi A, Kanazawa M, Miyashita H, Yoneda K, Kojima M, Nakanouchi T, Miki T, Benign Prostatic Hyperplasia Study Group of Kyoto Prefectural University of Medicine.
    BJU Int; 2005 Jul 01; 96(1):98-102. PubMed ID: 15963129
    [Abstract] [Full Text] [Related]

  • 18. [Transurethral prostatectomy with the bipolar plasmakinetic technique for benign prostate hyperplasia: a report of 712 cases].
    Che XY, Song XS, Wu DJ, Wang FP, Wang QF, Wang JB.
    Zhonghua Nan Ke Xue; 2009 May 01; 15(5):449-51. PubMed ID: 19514560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transurethral RollerLoop vapor resection of prostate for treatment of symptomatic benign prostatic hyperplasia: a 2-year follow-up study.
    Liu CK, Lee WK, Ko MC, Jeng HS, Chiang HS, Yu HJ.
    Scand J Urol Nephrol; 2006 May 01; 40(5):409-15. PubMed ID: 17060088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.